Insider · CIK 0001485417

Shannon James Samuel

Reports to the SEC for 5 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001485417

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2026-05-20	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+82.8K sh	—	—	82,781
2026-05-20	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+16.6K sh	—	—	16,556
2026-03-26	XLOXilio Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$8.79	+$43.9K	10,000
2026-03-01	MNKDMANNKIND CORPA Award	Director	AAward	+12K sh	$3.27	+$39.2K	64,635
2025-06-17	XLOXilio Therapeutics, Inc.P Purchase	Director	PPurchase	+25K sh	$0.69	+$17.2K	70,000
2025-06-16	XLOXilio Therapeutics, Inc.P Purchase	Director	PPurchase	+45K sh	$0.69	+$30.9K	45,000
2025-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-05-14	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+52.9K sh	—	—	52,854
2024-06-13	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-05-15	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+35K sh	—	—	35,047
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−23.6K sh	$116.50	−$2.75M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,150 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−33.2K sh	$116.50	−$3.86M	0
2023-09-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$12.19	+$144K	33,156
2023-09-29	Horizon Therapeutics Public Ltd CoStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	8,150
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-05-25	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+47.4K sh	—	—	47,393
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2023-04-28	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,879 sh	$111.16	−$209K	21,306
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	23,185
2022-05-10	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+45K sh	—	—	45,045
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	44,568
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-29	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,658 sh	$98.56	−$163K	42,910
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-05-20	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+11.3K sh	—	—	11,338
2021-05-20	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+33.9K sh	—	—	33,860
2021-04-30	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,357 sh	$94.62	−$412K	40,345
2021-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	44,702
2021-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,223 sh	—	—	4,223
2021-03-01	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,232 sh	—	—	20,000
2021-03-01	Horizon Therapeutics Public Ltd CoS Sale	Director	SSale	−7,232 sh	$91.30	−$660K	0
2021-03-01	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+7,232 sh	$12.19	+$88.2K	7,232
2020-08-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−3,221 sh	$61.19	−$197K	33,604
2020-08-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,204 sh	—	—	0
2020-08-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+8,204 sh	—	—	36,825
2020-05-21	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+88.2K sh	—	—	88,235
2020-05-21	MNKDMANNKIND CORP · Restricted Stock UnitA Award	Director	AAward	+38.8K sh	—	—	38,760
2020-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.4K sh	—	—	34,662
2020-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.4K sh	—	—	0
2020-05-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−6,041 sh	$35.62	−$215K	28,621
2020-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+11.1K sh	—	—	11,098
2019-09-13	Horizon Therapeutics Public Ltd CoS Sale	Director	SSale	−9,500 sh	$26.19	−$249K	0
2019-09-13	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+9,500 sh	$12.19	+$116K	9,500
2019-09-13	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,500 sh	—	—	27,232
2019-09-12	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	$12.19	+$189K	15,500

Recent filings

Accepted (ET)
Jun 124
Shannon James Samuel0001193125-26-269400
SEC(opens sec.gov)
May 224
Shannon James Samuel0001193125-26-237430
SEC(opens sec.gov)
Mar 304
Shannon James Samuel0001193125-26-131745
SEC(opens sec.gov)
Mar 34
Shannon James Samuel0001193125-26-089613
SEC(opens sec.gov)
Jun 184
Shannon James Samuel0001415889-25-017705
SEC(opens sec.gov)
Jun 124
Shannon James Samuel0001415889-25-016966
SEC(opens sec.gov)
May 164
Shannon James Samuel0000950170-25-073786
SEC(opens sec.gov)
Jun 174
Shannon James Samuel0001415889-24-017160
SEC(opens sec.gov)
May 174
Shannon James Samuel0000950170-24-062085
SEC(opens sec.gov)
Oct 64
Shannon James Samuel0001209191-23-052370
SEC(opens sec.gov)
Oct 24
Shannon James Samuel0001209191-23-051231
SEC(opens sec.gov)
Jul 284
Shannon James Samuel0001209191-23-043691
SEC(opens sec.gov)
May 264
Shannon James Samuel0001209191-23-032732
SEC(opens sec.gov)

Companies

Address

828 WINTER STREET SUITE 300

WALTHAM, MA, 02478